Canton Hathaway, LLC Immutep LTD Transaction History

Canton Hathaway, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 10, 2019	SELL	$1.97 - $2.57 $33,490 - $43,690	-17,000 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$1.84 - $3.9 $12,328 - $26,130	6,700 Added 65.05%	17,000 $31,000
Q3 2018 Oct 12, 2018	BUY	$2.45 - $3.7 $25,235 - $38,110	10,300 New	10,300 $38,000

1.86M

264K

90.5K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $172M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

Stay updated on Canton Hathaway, LLC with notifications on news.